Enliven Therapeutics, Inc. (Enliven or the Company) , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced updated, ...

New research shows marijuana-related hospitalizations are increasing among older adults, and also suggests that these ...

In a global first for Africa, UCT is participating in a clinical trial to reprogramme genes and halt hereditary angioedema.

Kancera AB (publ) (Kancera) today reports the top-line results from the KANDOVA study, a one-arm, open-label, multi-centre combined phase Ib/IIa study of KAND567 in combination with carboplatin in ova ...

“As it stands now, no competent defense counsel would call Mr. Proctor,” Jack Lu, a retired superior court judge, said in an interview before Read’s defense rested this week. “He has the ability to ...

In June 2025, AstraZeneca announced a Phase III study to determine the efficacy and safety of durvalumab + tremelimumab ...

Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients – – Promising clinical activity and deep responses observed ...

Reducing supplementary oxygen given to intensive care patients does not deliver any clear and obvious health benefits or harm ...

Dr. Maroouf is a clinical scientist and analog astronaut. From simulating life on Mars at the Mars Desert Research Station to exploring healthcare technologies for astronauts, Dr. Maroouf shares how ...

Photo: Qu Dacheng, Vice Mayor of Chaoyang District, delivers remarks at the Global Investment Cooperation Trends Forum ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced plans to initiate a multi-national clinical trial ...